Naloxone Cloridrato Adulti Molteni (Naloxone Hydrochloride)

Naloxone binds competitively to μ‑opioid receptors with higher affinity than most opioid agonists. By displacing the opioid molecules, it blocks their activity, quickly reversing respiratory depression, sedation, and other opioid‑mediated effects without activating the receptors itself.

The exact dose of naloxone is determined by the prescribing clinician based on the severity of the overdose, the route of administration, and the patient’s response. Dosage may be adjusted in an emergency setting to achieve adequate reversal of opioid effects.

Limited clinical data exist for naloxone use in pregnancy and lactation. It should be administered only if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under the guidance of a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Naloxone has a rapid onset of action and a short duration, making it ideal for emergency reversal of opioid overdose. Naltrexone, in contrast, has a longer half‑life and is used primarily for maintenance therapy in opioid dependence, not for acute emergency treatment.

Naloxone Cloridrato Adulti Molteni should be stored below 25 °C in its original packaging. Protect the solution from light, moisture, and extreme temperature fluctuations to maintain potency and sterility.

Naloxone can be given intramuscularly, intravenously, or subcutaneously. The typical approach is a rapid injection into a large muscle (e.g., thigh) or an IV push, followed by observation of the patient’s respiratory status and repeat dosing if necessary.

The most serious risks include precipitating acute opioid withdrawal, which can cause severe hypertension, tachycardia, agitation, or seizures, and rare allergic reactions such as anaphylaxis. Immediate medical monitoring is essential after administration.

Naloxone is contraindicated in individuals with known hypersensitivity to naloxone or any of its excipients. Caution is advised in patients with severe cardiovascular disease, as rapid reversal of opioid effects may provoke abrupt hemodynamic changes.